CEACAM5 and metastatic neoplasm: Up to one-third of patients with localized colorectal cancer (CRC) relapse after curative-intent resection, as conventional markers like carcinoembryonic antigen (CEA) and scheduled CT/MRI often fail to detect micro-metastatic disease early.